Concepedia

Jason Marineau

JM

Statistics

Publications

11

Citations

1.3K

H-Index

10

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Paraza Pharma (Canada)

University of Colorado Boulder

Brigham and Women's Hospital

Jason Marineau is an author at Dana-Farber Cancer Institute specializing in drug discovery, pharmacology, and molecular oncology.

ORCID

Publications per year

2012–2025

11

Publications

11

Catalytic site remodelling of the DOT1L methyltransferase by selective inhibitors

Wenyu Yu, Emma J. Chory, Amy K. Wernimont et al. · Nature Communications · 2012 · 286 citations · Full text

, , +13

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia

Alejandro Gutiérrez, Pan Li, Richard W.J. Groen et al. · Journal of Clinical Investigation · 2014 · 222 citations · Full text

, , +15

Genome-wide determination of drug localization

Lars Anders, Matthew G. Guenther, Jun Qi et al. · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · 2014 · 182 citations · Full text

, , +4

Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7

Shanhu Hu, Jason Marineau, Nisha Rajagopal et al. · Cancer Research · 2019 · 151 citations

, , +15

Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent

Michael Xiang, Haesook Kim, Vincent T. Ho et al. · Blood · 2016 · 113 citations · Full text

, , +9

1–5 of 11